Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

INTRODUCTION: The α-glucosidase inhibitor acarbose is an efficacious medicine for the treatment and prevention of type 2 diabetes mellitus (T2DM). However, the response of gut microbiota to acarbose is important, as the microbiota may have a critical role in the development of metabolic diseases, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiuying, Fang, Zhiwei, Zhang, Chunfang, Xia, Huihua, Jie, Zhuye, Han, Xueyao, Chen, Yingli, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380489/
https://www.ncbi.nlm.nih.gov/pubmed/28130771
http://dx.doi.org/10.1007/s13300-017-0226-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380489/
https://www.ncbi.nlm.nih.gov/pubmed/28130771
http://dx.doi.org/10.1007/s13300-017-0226-y

Ejemplares similares